Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Glossopharyngeal neuralgia is a condition characterized by repeated episodes of severe pain in the tongue, throat, ear, and tonsils (areas connected to the ninth cranial nerve, or glossopharyngeal nerve). It typically occurs in individuals over age 40. Episodes of pain may last from a few seconds to a few minutes, and usually occur on one side. The pain may be triggered by swallowing, speaking, laughing, chewing or coughing. The condition is thought to be due to irritation of the nerve, although the source of irritation is unclear. The goal of treatment is to control pain, but over-the-counter pain medications are not very effective; the most effective drugs are anti-seizure medications. Some antidepressants help certain people. Surgery to cut or take pressure off of the glossopharyngeal nerve may be needed in severe cases.
Biomarker and diagnostic research for glossopharyngeal neuralgia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
179 publications have been identified in PubMed for glossopharyngeal neuralgia. Research spans Review / Meta-Analysis (39%), Basic Science / Preclinical (23%), and Case Report / Case Series (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 69 | 39% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
42 |
23% |
Patient case studies | 29 | 16% |
Clinical study results | 22 | 12% |
Disease patterns and progression | 11 | 6% |
Testing and diagnosis research | 3 | 2% |
New treatment approaches | 2 | 1% |
Other research | 1 | 1% |
Chang PS (2026). [PMID: 41813057](https://pubmed.ncbi.nlm.nih.gov/41813057/). *RMD Open*. [Review / Meta-Analysis]
Nisar A (2026). [PMID: 41773147](https://pubmed.ncbi.nlm.nih.gov/41773147/). *Cureus*. [Case Report / Case Series]
Farah A (2026). [PMID: 40744832](https://pubmed.ncbi.nlm.nih.gov/40744832/). *Trends Mol Med*. [Review / Meta-Analysis]
Yamashiro K (2026). [PMID: 41741133](https://pubmed.ncbi.nlm.nih.gov/41741133/). *Head & neck*. [Case Report / Case Series]
Xu Y (2026). [PMID: 42181615](https://pubmed.ncbi.nlm.nih.gov/42181615/). *Front Pain Res (Lausanne)*. [Case Report / Case Series]
Quodling N (2026). [PMID: 41683658](https://pubmed.ncbi.nlm.nih.gov/41683658/). *Int J Mol Sci*. [Review / Meta-Analysis]
Pătrășcan AM (2026). [PMID: 42042753](https://pubmed.ncbi.nlm.nih.gov/42042753/). *Neurol Int*. [Review / Meta-Analysis]
Maksymowicz R (2026). [PMID: 41953930](https://pubmed.ncbi.nlm.nih.gov/41953930/). *Clin Med Insights Case Rep*. [Case Report / Case Series]
Weiger VF (2026). [PMID: 41699350](https://pubmed.ncbi.nlm.nih.gov/41699350/). *Neurosurgical review*. [Basic Science / Preclinical]
Zhang W (2026). [PMID: 41696930](https://pubmed.ncbi.nlm.nih.gov/41696930/). *The Journal of craniofacial surgery*. [Clinical Trial Publication]
AI-curated news mentioning glossopharyngeal neuralgia
Updated Feb 16, 2026
A study evaluates the efficacy of microvascular decompression and selective nerve root dissection for treating trigeminal neuralgia combined with glossopharyngeal neuralgia. The findings contribute to understanding treatment options for these painful conditions.